Overview

Detailed Summary

Rossari Biotech Limited is a leading manufacturer of specialty chemicals, offering sustainable chemical solutions across various industries including HPPC, TSC, and AHN.
The company reported a 13% year-on-year revenue growth for Q3 FY26, driven by strong performance in international markets and steady growth across its core business segments.
Rossari has recently received board approval to establish a new greenfield manufacturing facility in Saudi Arabia, aimed at enhancing its global supply chain capabilities and expanding its international footprint.
Despite ongoing investments and capacity expansion efforts, Rossari maintains a solid financial structure with healthy liquidity, facilitating continued strategic growth initiatives.
The company's focus on R&D and innovation is evident in the introduction of new environmentally benign chemical solutions and strategic acquisitions to enhance its product portfolio.

Sector: Chemicals & Petrochemicals
Industry: Specialty Chemicals
Market Cap: 2,708 Cr
Volatility: High Risk
P/E Ratio: 18.2
Industry P/E: 42.3
PEG Ratio: 1.4
P/B Ratio: 2.0
52W High: 767.55
52W Low: 372.90

Sales CAGR

1Y: 13.64%
3Y: 10.09%
5Y: 18.99%
10Y: —

Profit CAGR

1Y: 4.35%
3Y: 13.02%
5Y: 11.86%
10Y: —

ROE

TTM: 11.19%
3Y: 9.87%
5Y: 10.88%
10Y: 13.19%

ROCE

TTM: 13.06%
3Y: 13.66%
5Y: 14.99%
10Y: 17.92%

Technicals

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
JUBLCPL		1820.00	2,758 Cr	21.57	6.00	0.00	27.80	34.27	13.67
ROSSARI		486.00	2,708 Cr	18.15	2.03	0.10	11.19	13.06	6.52
TATVA		1154.75	2,698 Cr	64.16	3.45	0.17	5.38	6.63	4.19
NOCIL		157.00	2,606 Cr	46.84	1.47	0.96	3.14	4.35	2.64
DDEVPLSTIK		246.20	2,563 Cr	12.70	2.53	0.71	19.92	28.27	13.98
CAMLINFINE		125.25	2,408 Cr	87.15	2.31	0.00	1.18	3.77	1.01
BEPL		94.00	2,341 Cr	12.99	2.16	4.25	16.63	22.86	14.02
Median: 7 Co.	—	246.20	2,606 Cr	21.57	2.31	0.17	11.19	13.06	6.52

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	464	473	490	498	513	580	544	586	582	685
Expenses	400	409	425	432	448	510	476	514	513	608
Operating Profit	64	64	65	66	65	69	68	72	69	77
OPM %	13.73	13.45	13.25	13.23	12.63	11.99	12.48	12.27	11.84	11.28
Other Income	3.52	0.57	1.16	1.01	0.88	1.94	1.72	2.07	0.91	20
Interest	4.32	2.52	3.69	3.68	4.94	5.50	5.73	6.09	7.67	9.06
Depreciation	15	16	15	15	18	18	18	18	20	24
Profit Before Tax	48	46	47	48	42	48	46	50	43	64
Tax %	28.02	25.10	25.73	26.56	25.20	27.79	27.11	25.77	22.89	28.46
Net Profit	34	34	35	35	32	34	34	37	33	46
EPS in Rs	6.19	6.15	6.28	6.38	5.72	6.21	6.06	6.65	5.91	8.29

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	516	600	709	1,483	1,656	1,831	2,080	2,134
Expenses	439	495	586	1,300	1,433	1,581	1,815	1,866
Operating Profit	78	105	124	183	223	250	265	268
OPM %	15.02	17.45	17.42	12.37	13.47	13.64	12.74	12.56
Other Income	0.91	3.51	9.12	14	6.44	7.62	4.99	5.55
Interest	2.88	3.56	2.99	13	22	19	18	20
Depreciation	12	17	23	48	63	60	67	69
Profit Before Tax	63	88	107	136	144	178	185	184
Tax %	27.94	25.71	25.08	28.31	25.63	26.42	26.36	26.71
Net Profit	46	65	80	98	107	131	136	135
EPS in Rs	—	13.37	14.79	17.54	19.29	23.54	24.59	26.91
Dividend Payout %	0.00	3.78	3.23	2.82	2.58	2.12	2.03	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	4.40	10	10	11	11	11	11
Reserves	119	277	398	794	904	1,037	1,174
Borrowings	3.94	61	0.00	8.43	74	119	218
Other Liabilities	122	124	153	443	378	406	493
Total Liabilities	250	472	561	1,257	1,368	1,572	1,896
Fixed Assets	74	94	181	607	585	578	598
CWIP	2.83	22	0.32	1.34	16	47	140
Investments	0.00	18	0.00	36	51	63	84
Other Assets	173	338	380	612	715	885	1,074
Total Assets	250	472	561	1,257	1,368	1,572	1,896

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	71	57	48	29	152	43	137
Cash from Investing Activity	-36	-190	-37	-299	-181	-103	-184
Cash from Financing Activity	-29	157	-25	292	61	16	65
Net Cash Flow	5.61	23	-14	22	32	-44	19

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	68.43%	68.35%	68.33%	68.32%	68.32%	68.27%	68.19%	68.18%	68.17%	68.17%	68.16%	68.15%
FIIs	6.12%	5.75%	4.14%	4.03%	3.83%	3.74%	3.74%	3.98%	3.48%	2.69%	2.33%	2.18%
DIIs	17.71%	17.68%	18.06%	17.75%	16.87%	17.34%	17.47%	17.59%	17.84%	18.18%	18.26%	18.20%
Public	7.73%	8.23%	9.46%	9.90%	10.98%	10.65%	10.60%	10.25%	10.51%	10.95%	11.26%	11.46%
Total Shareholders	95,371	95,200	1,00,423	98,859	1,00,475	97,188	95,735	92,852	91,791	91,387	89,249	86,972

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY26

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Available on Pro Plan